Stacy Chin tells founders worried about SBIR/STTR disappearing that the programs will continue for at least another year. She explains how this non-dilutive funding lets you build without giving up equity, and advises doubling down on applications across multiple agencies to turn uncertainty into advantage.
They're freaking out, wondering what's happening with the situation and if SBIR and STTR opportunities are going to vanish overnight. Some are scrambling to rewrite budgets, others are calling investors, and a few are just trying to figure out what is next if this lifeline disappears. When something critical feels uncertain, it shakes founders to their core. But take a deep breath because here's the truth: you're okay for another year. So the SBIR and STTR program give founders something that venture capitalists can't really give them: time and freedom to build without dilution. Because let's face it, the SBIR The SBIR/STTR program allows that PhD researcher to spin out their first company from a research lab. But this year, these programs are leading to huge question marks in founders' heads. They're left in limbo, staring at the deadline, not knowing when the next funding round's gonna come even next. They're thinking about survival, how to keep the labs open, how to keep their engineers and scientists paid, how to keep the ideas alive in a system that can feel like it vanishes overnight. So I know you're asking, what should founders do now? And here's what we've been saying: double down on submission. Because during times of uncertainty, we find that everyone's holding back. But that means that's your competition and window of opportunity to get ahead. If you're focused on submitting SBIR applications in one agency, this is a great time to look across different agencies and see if you are a fit.
Applying for NIH SBIR in Jan 5, 2027? You Should Be Starting NOW. Here's why...
How to Get Invited to Apply for $305K in NSF SBIR Funding || Step-by-Step Guide
